Biotechnology

September 08, 2016

//
Posted By
/
Comment0
/
Categories
EpiPen Pricing: Much Ado About Nothing   Drug prices are back in the news, this time focused on the epinephrine auto-injector marketed by Mylan [NASDAQ:  MYL] as “EpiPen.”  EpiPen is a life-saving product for those at risk of anaphylaxis —...
Read More →

May 5, 2016

//
Posted By
/
Comment0
/
Categories
Biotech:  Still An Innovation Engine   Biotech had a tough second half of 2015, and a tough beginning to 2016; between July’s high last year, and the February 2016 low, the Nasdaq Biotechnology Index (NBI) registered a nearly 40 percent...
Read More →

March 20, 2014

//
Posted By
/
Comment0
/
Bioprinting: Applications May Be Closer Than You ThinkIn previous issues of this letter we’ve commented on 3D printing developments. Companies such as 3D Systems (NYSE: DDD), Stratasys (NASD: SSYS), and ExOne (NASD: XONE) may be familiar to investors who have investigated this...
Read More →